These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. Goldstein EJ, Citron DM, Cherubin CE, Hillier SL. J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570 [Abstract] [Full Text] [Related]
5. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983. Nord CE, Olsson-Liljequist B. Scand J Infect Dis Suppl; 1984 Mar; 43():44-9. PubMed ID: 6100139 [Abstract] [Full Text] [Related]
7. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents. Jones RN, Barry AL, Packer RR. Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925 [Abstract] [Full Text] [Related]
8. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua. Cáceres M, Carera E, Palmgren AC, Nord CE. Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308 [Abstract] [Full Text] [Related]
9. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria. Prabhala RH, Thadepalli H, Rao B, Bansal MB, Marshall R. Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195 [Abstract] [Full Text] [Related]
10. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria. Wells CL, Wilkins TD. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546 [Abstract] [Full Text] [Related]
11. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics. Glupczynski Y, Gordts B, van der Linden MP, Labbé M, Yourassowsky E, Butzler JP. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548 [Abstract] [Full Text] [Related]
12. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg. van der Westhuyzen I, Chalkley LJ. S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710 [Abstract] [Full Text] [Related]
13. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria. Shafran SD, Wong J, Chow AW. Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069 [Abstract] [Full Text] [Related]
14. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals. Goldstein EJ, Citron DM. Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600 [Abstract] [Full Text] [Related]
15. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin]. Dubreuil L, Derriennic M, Reynaud A, Devos J, Romond C, Courtieu A. Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082 [Abstract] [Full Text] [Related]
19. The in vitro activity of trospectomycin against anaerobic bacteria. Chisari G, Lo Bue AM, Nicoletti G. J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035 [Abstract] [Full Text] [Related]
20. In vitro activity of cefbuperazone against anaerobic bacteria. Wexler H, Carter WT, Harris BH, Finegold SM. Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]